ResearcherSouthwest Medical UniversityNo recent work listed

Anguo Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9850-7576; OpenAlex author ID A5047119468. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic C… Last author DOI 10.3390/molecules28207205 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huijie Gao · 1 shared paper, 2023 · strength 0.18
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205 ↗
Yuntao Zhang · 1 shared paper, 2023 · strength 0.18
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205 ↗
Qiang Ren · 1 shared paper, 2023 · strength 0.18
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205 ↗
Lufen Huang · 1 shared paper, 2023 · strength 0.18
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.